Science publishes today a Science & Policy article about regulation of the famous Direct-To-Consumer (DTC) genome testing. An interesting discussion highlighting the crucial importance of joint efforts:

Effective regulation will require cooperation from governmental agencies, and flexibility to accommodate the complexities of tests, like those offered by DTC companies, that provide genome-wide analysis producing results with variable and often uncertain validity and clinical utility.